Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

LifeTech TaqMan Integrates with Genedata Expressionist for Genomic Profiling

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
Genedata partners with Life Technologies to expedite NGS data analysis and real-time PCR-based validation.

Genedata announced a partnership with Life Technologies Corporation designed to create a streamlined ecosystem that empowers researchers in both academic and commercial settings to accelerate discovery and validation experiments. As part of the collaboration, Genedata will integrate Life Technologies’ online store with the Genedata biomarker discovery platforms Genedata Expressionist® for Genomic Profiling and Genedata Analyst - enabling users to easily purchase TaqMan® real-time PCR assays specific to their next generation sequencing (NGS) data.

Within the Genedata/LifeTechnologies workflow, Genedata solutions process and analyze data and when marker candidates are identified, users seamlessly connect to the Life Technologies’ online store for TaqMan® Assay purchase. With a couple of clicks, PCR assays are selected and ordered for all marker candidates. Upon receipt of PCR assays, users can validate experiments in an integrative manner by loading the raw PCR data directly into the same session that was used for identifying marker candidates.

“Life Technologies and Genedata share a common goal of advancing research and facilitating scientific discovery,” said Chris Linthwaite, Head of Genetic Analysis at Life Technologies. “Integration of our complementary technologies serves that mission by providing researchers quick access to the most appropriate TaqMan assays to validate data from their NGS experiments.”

Thriving on large and complex experimental data sets, Genedata Expressionist for Genomic Profiling is easily integrated into existing research environments. The direct interface with TaqMan® real-time PCR assays is available for a variety of applications, including DNA-, RNA, Chip-, and Methyl-Seq, SNP genotyping, and copy number analysis.

“Our collaboration with Life Technologies reflects our vision to enrich the research experience for our customers with innovative solutions that also drive down costs with time-saving workflows,” noted Dr. Othmar Pfannes, CEO of Genedata. “With Genedata Expressionist, researchers have the power of rich statistical and visualization tools to analyze NGS data, and these capabilities are now complemented with real-time PCR to quickly validate genomic experiments.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genedata Completes Important Milestone in Collaboration with Bayer Pharma AG
Successful integration of Genedata Profiler™ allows researchers to access, process, analyze and manage petabytes of NGS and other omics data from patients and pre-clinical experiments.
Thursday, September 24, 2015
Genedata Forges Alliance with Intellicyt
Swiss informatics firm Genedata and Intellicyt today announced an alliance to work on cell-based screening in drug discovery.
Thursday, June 18, 2015
Genedata Highlights Combination Screening and Surface Plasmon Resonance at SLAS 2015
Colloquium and tutorials on Combination Screening and SPR examine Genedata Screener as the platform for all plate-based screening experiments.
Wednesday, February 04, 2015
Exploring Innovations in SPR & Combination Screening
Genedata customers will discuss innovations in high content imaging, high throughput screening, compound combination screening, and other related topics at User Group Meetings.
Tuesday, August 26, 2014
Axxam Advances Its High-Throughput Screening with Genedata Screener
Leading contract research and discovery organization capitalizes on Genedata Screener flexibility to tailor data analysis for customer-specific screening and hit-to-lead services
Tuesday, December 06, 2011
Genedata Unveils New Japanese Web Site for Expanding Pharma R&D and Life Science Business
New web site closely follows an expansion of Genedata in Japan and supports the growing customer base in Asia.
Monday, November 16, 2009
Genedata Strengthens TcLand Expression’s Research Informatics Infrastructure for Personalized Medicine
Genedata Phylosopher® and Expressionist® biomarker discovery platforms to be integrated into TcLand Expression’s computational infrastructure.
Thursday, April 09, 2009
Genedata and Roche Extend MS-based Proteomics Biomarker Discovery Collaboration
Collaboration extends three-year license with Roche for the Refiner MS module of the Genedata Expressionist® biomarker discovery system.
Thursday, February 05, 2009
Multi-Year Contract Extension with Nycomed for Genedata Screener
Genedata will create a global scientific computing infrastructure for the lead discovery and drug research programs at Nycomed sites worldwide.
Tuesday, January 15, 2008
Genedata Opens Subsidiary in Tokyo
Genedata’s new offices based in Japan will provide local support for life sciences research with a focus on pharmaceutical research.
Wednesday, June 27, 2007
Scientists at Genedata Enhance Cell Based Screening Workflow
Genedata is collaborating with imaging technology providers to enhance automation and standardization for the analysis of cell based assays.
Friday, April 13, 2007
Genedata in Screening Analysis Collaboration with Chugai Pharmaceutical
Genedata’s computational scientists in Japan have integrated Genedata Screener® with Chugai’s screening platforms and result databases.
Tuesday, February 20, 2007
Global Expansion of Genedata’s Screening Analysis Collaboration with Roche
The multi-year expansion of the collaboration will include all Roche high HTS facilities in North America and Europe.
Monday, December 19, 2005
GeneData and Novartis expand Collaboration

Thursday, February 13, 2003
GeneData Releases Two Data Analysis Modules for its Screener™ Software

Friday, November 22, 2002
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos